Vermillion has appointed director Bruce Huebner as its interim CEO. Huebner succeeds former CEO Gail Page, who will be strategic advisor to the company and continue to serve on the board of directors.
A week after Hurricane Sandy pummeled the East coast, sequencing facilities across New York City and at Cold Spring Harbor Laboratory on Long Island are starting to get back to business as usual.
The New York Genome Center has launched its Innovation Center, which will test new and emerging sequencing technologies and is about to install its first platform, Life Technologies' Ion Proton.
NEW YORK (GenomeWeb News) — The New York Genome Center launched its "Innovation Center" today, which will provide its founding members with access to new sequencing technologies.
A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.
An Australian mother's conviction in the deaths of her children may be re-examined after finding that two of the children carried a cardiac arrhythmia-linked gene variant.
